199 related articles for article (PubMed ID: 21151591)
1. Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer.
Tian S; Roepman P; Van't Veer LJ; Bernards R; de Snoo F; Glas AM
Biomark Insights; 2010 Nov; 5():129-38. PubMed ID: 21151591
[TBL] [Abstract][Full Text] [Related]
2. [Validation and clinical application of MammaPrint® in patients with breast cancer].
Cuadros M; Llanos A
Med Clin (Barc); 2011 May; 136(14):627-32. PubMed ID: 20416899
[TBL] [Abstract][Full Text] [Related]
3. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
[TBL] [Abstract][Full Text] [Related]
4. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
[TBL] [Abstract][Full Text] [Related]
5. Performance characteristics of the MammaPrint
Delahaye LJ; Wehkamp D; Floore AN; Bernards R; Van't Veer LJ; Glas AM
Per Med; 2013 Nov; 10(8):801-811. PubMed ID: 29776281
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression.
Cook AC; Tuck AB; McCarthy S; Turner JG; Irby RB; Bloom GC; Yeatman TJ; Chambers AF
Mol Carcinog; 2005 Aug; 43(4):225-36. PubMed ID: 15864800
[TBL] [Abstract][Full Text] [Related]
8. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancer.
Gevensleben H; Göhring UJ; Büttner R; Heukamp LC; Kunz G; Dimpfl T; Jackisch C; Ortmann O; Albert US; Bender R; De Snoo F; Krijgsman O; Glas AM; Ergönenc YH; Vogel C; Dykgers A; Langwieder C; Rees M; Anzeneder T
Int J Mol Med; 2010 Dec; 26(6):837-43. PubMed ID: 21042777
[TBL] [Abstract][Full Text] [Related]
10. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
Eur J Cancer; 2017 Apr; 75():5-13. PubMed ID: 28214658
[TBL] [Abstract][Full Text] [Related]
11. [Validation and clinical application of MammaPrint
Sánchez-Forgach ER; Carpinteyro-Espín U; Alemán-Áviles JA; Sánchez-Basurto C
Cir Cir; 2017; 85(4):320-324. PubMed ID: 27979362
[TBL] [Abstract][Full Text] [Related]
12. Identification of Cancer Hallmarks Based on the Gene Co-expression Networks of Seven Cancers.
Yu LH; Huang QW; Zhou XH
Front Genet; 2019; 10():99. PubMed ID: 30838028
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
15. Prospective Validation of a Genomic Assay in Breast Cancer: The 70-gene MammaPrint Assay and the MINDACT Trial.
Audeh W; Blumencranz L; Kling H; Trivedi H; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):18-34. PubMed ID: 31264430
[TBL] [Abstract][Full Text] [Related]
16. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients.
Slodkowska EA; Ross JS
Expert Rev Mol Diagn; 2009 Jul; 9(5):417-22. PubMed ID: 19580427
[TBL] [Abstract][Full Text] [Related]
17. Revisiting 'Hallmarks of Cancer' In Sarcomas.
Honoki K; Tsujiuchi T; Kishi S; Kuniyasu H
J Cancer; 2024; 15(7):1786-1804. PubMed ID: 38434982
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis for the identification of key genes and long non-coding RNAs related to bone metastasis in breast cancer.
Teng X; Yang T; Huang W; Li W; Zhou L; Wang Z; Feng Y; Zhang J; Yin X; Wang P; Li G; Yu H; Chen Z; Fan D
Aging (Albany NY); 2021 Jul; 13(13):17302-17315. PubMed ID: 34226298
[TBL] [Abstract][Full Text] [Related]
19. Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin.
Sharma P; Alsharif S; Fallatah A; Chung BM
Cells; 2019 May; 8(5):. PubMed ID: 31126068
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
